Source: Eur Respir J 2014; 44: 523-527



Rating:

Share or cite this content

Citations should be made in the following way:
Beynat-Mouterde Caroline, Beltramo Guillaume, Lezmi Guillaume, Pernet Didier, Camus Clio, Fanton Annlyse, Foucher Pascal, Cottin Vincent, Bonniaud Philippe. Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents. Eur Respir J 2014; 44: 523-527

Member's Comments

No comment yet.

Related content which might interest you: Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection? Source: Eur Respir J 2013; 41: 243-245 Year: 2013 Treatment with nintedanib in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017 A rare pulmonary complication of myeloma therapy Source: Case Report 2014 Year: 2014 A rare pulmonary complication of myeloma therapy Source: Breathe 2014; 10: 243-248 Year: 2014 Predicting factors for mortality in patients with pleuroparenchymal fibroelastosis Source: International Congress 2017 – Rare diseases Year: 2017 Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia Source: ERJ Open Res, 7 (1) 00196-2020; 10.1183/23120541.00196-2020 Year: 2021 Clinical and pathological features of idiopathic and secondary pleuroparenchymal fibroelastosis in patients undergoing lung transplantation Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Clinical courses of asymptomatic patients with mild idiopathic pleuroparenchymal fibroelastosis Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children Year: 2018 Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes Source: Eur Respir J 2012; 40: 377-385 Year: 2012 Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Platypnoea orthodeoxia syndrome: a rare complication of pneumonectomy Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004 Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Source: Eur Respir J 2015; 45: 1183-1186 Year: 2015 Endometriosis-associated pneumothorax: “uncommon” disease Source: International Congress 2019 – Thoracic surgery Year: 2019 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation? Source: International Congress 2017 – ME10 Pleuroparenchymal fibroelastosis: what have we learned from lung transplantation? Year: 2017 Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism Source: Eur Respir J 2016; 48: 1360-1368 Year: 2016 Balanced indications for surgery or endobronchial therapy for typical carcinoid tumours Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 The features of rare pulmonary tumors and their surgical treatment Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020 Pleuroparenchymal fibroelastosis: report of 4 cases Source: International Congress 2017 – Rare diseases Year: 2017 Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 Carcinomatous lymphangitis of a tracheal bifurcation in lung cancer: the role of neoadjuvant chemotherapy followed by surgery Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008